FDA Approves First Gene Therapy to Treat Adults with Hemophilia B

FDA approves Hemgenix, an adeno-associated virus vector-based gene therapy indicated for treatment of adults with Hemophilia B (congenital Factor IX deficiency)
Click here to view original post